Please login to the form below

Not currently logged in
Email:
Password:

long-term condition

This page shows the latest long-term condition news and features for those working in and with pharma, biotech and healthcare.

NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia

NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia

NICE’s positive recommendation for asciminib means that physicians can now consider an innovative treatment for people living with chronic myeloid leukaemia, a long-term debilitating and life-threatening condition,” said

Latest news

  • Amgen’s Riabni combination granted FDA approval for rheumatoid arthritis Amgen’s Riabni combination granted FDA approval for rheumatoid arthritis

    Rheumatoid arthritis is a long-term condition that causes painful swelling and stiffness in the joints. ... RA is a long-term condition that causes intense pain, stiffness and swelling in the joints, with the condition typically affecting the hands,

  • NICE recommends AZ’s Forxiga for kidney disease NICE recommends AZ’s Forxiga for kidney disease

    CKD is a long-term condition where the patient’s kidney function is severely reduced, affecting the kidney’s ability to remove waste products from the body. ... The condition is a considerable burden on the UK healthcare system, representing 1.3% of

  • Tonix Pharmaceuticals to develop TNX-102 for long COVID syndrome Tonix Pharmaceuticals to develop TNX-102 for long COVID syndrome

    In a statement, Tonix said that long COVID syndrome symptoms – including pain, sleep disturbance, fatigue and brain fog – overlap with fibromyalgia, another long-term condition characterised by widespread musculoskeletal pain. ... Long COVID has been

  • Healthcare’s voice revolution Healthcare’s voice revolution

    When we asked smart tech users with a long-term condition who they wanted to see leading the way in this field, 55% said healthcare providers and 52% said tech companies. ... The other is to prove conclusively to prescribers that the integration of voice

  • CHMP nod for Alexion, GSK drugs, revocation for Lartruvo CHMP nod for Alexion, GSK drugs, revocation for Lartruvo

    By giving patients a simpler regimen containing fewer drugs, the expectation is that long term management of the condition will be easier, with patients less likely to develop side-effects.

More from news
Approximately 0 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions

    Knowing what patients struggle with and what drives their health behaviour is crucial in identifying how best to support them in managing their condition. ... Take a 360 view: when people lack resources, they focus their attention on immediate needs and

  • How can pharma better engage and empower patients who are socially disadvantaged? How can pharma better engage and empower patients who are socially disadvantaged?

    have a long-term health condition than those who are the least disadvantaged. ... Pharma has long been the driver of health education campaigns, either themselves or in partnership with patient associations.

  • Behavioural science in 2030 Behavioural science in 2030

    A report published by the World Health Organization in 2003 concluded that between a third and a half of medicines prescribed for long-term conditions are not taken as directed. ... Each individual being treated for a long-term condition will receive a

  • A patient's eye view of the digital doctor A patient's eye view of the digital doctor

    Doctors, patients and using new technologies and social media to help with a long-term condition. ... Now in his 40s, he requires life-long medical help, and represents many chronic patients who require constant monitoring and doctor visits.

  • Interview: David Haslam, NICE Interview: David Haslam, NICE

    There's such a clear overlap between them.”. “At the moment we have this extraordinary situation where patients are kept in hospital a long time, inappropriately and expensively, because of a ... Noting that there are more patients with two or more

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Mednet Group

PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....